Meeting
2013 ASCO Annual Meeting
Phase I trial of sorafenib, bevacizumab, and temsirolimus in advanced solid tumors.
Authors
Shannon Neville Westin
The University of Texas MD Anderson Cancer Center, Houston, TX
Shannon Neville Westin , Melody L. Smart , Navdeep Pal , Diana L Urbauer , Filip Janku , Jennifer J. Wheler , Sarina Anne Piha-Paul , Aung Naing , Apostolia Maria Tsimberidou , Siqing Fu , Gerald Steven Falchook , David S. Hong , Ralph Zinner , Vivek Subbiah , Kirk Salvatore Culotta , Karen H. Lu , Robert L. Coleman , Razelle Kurzrock
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics - Clinical Pharmacology and Experimental Therapeutics
Track
Developmental Therapeutics
Sub Track
PI3-Akt-mTOR Pathway
Clinical Trial Registration Number
NCT01187199
Citation
J Clin Oncol 31, 2013 (suppl; abstr 2611)
DOI
10.1200/jco.2013.31.15_suppl.2611
Abstract #
2611
Poster Bd #
10G
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Phase 1/2 evaluation of revumenib in patients with advanced colorectal cancer and other solid tumors.
First Author: Aparna Raj Parikh
Poster
2016 ASCO Annual Meeting
Phase I trial of paclitaxel, bevacizumab, and temsirolimus in advanced solid malignancies.
First Author: Shannon Neville Westin
Poster
2015 ASCO Annual Meeting
A phase I trial everolimus and sorafenib in patients with recurrent high-grade gliomas: Brain Tumor Treatment Collaborative trial 09-01.
First Author: Jeffrey J. Raizer
Poster
2012 Gastrointestinal Cancers Symposium
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors.
First Author: Fatima A. Rangwala